05:28 PM EDT, 08/13/2024 (MT Newswires) -- Matthew E Korenberg, President & COO, on August 09, 2024, sold 18,245 shares in Ligand Pharmaceuticals ( LGND ) for $1,797,133. Following the Form 4 filing with the SEC, Korenberg has control over a total of 68,368 shares of the company, with 68,368 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/886163/000200101124000071/xslF345X03/edgardoc.xml